Study to Evaluate QR-110 in Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Clinical trial NCT03140969 · COMPLETED
Trial details
- NCT number
- NCT03140969
- Sponsor
- Laboratoires Thea
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2019-10-02
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.